Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Angioplasty Stent, Catheters (IVUS/OCT), Plaque Modification, Vascular Closure Devices, Balloon Inflation Devices, Hemodynamic Flow Alteration), End User - Global Forecast to 2031

The peripheral vascular devices market is projected to reach USD 13.22 billion by 2031 from USD 10.02 billion in 2026, at a CAGR of 5.7% from 2026 to 2031.

The peripheral vascular devices market is experiencing significant growth, driven by the rising prevalence of peripheral artery disease (PAD) and other vascular disorders. These conditions are largely linked to the aging population, along with rising rates of diabetes, obesity, and smoking. Innovations in minimally invasive endovascular devices, such as drug-coated balloons, next-generation stents, atherectomy systems, and embolic protection devices, are greatly improving clinical outcomes and expanding the range of patients who can be treated. Additionally, the growing preference for outpatient and ambulatory surgical center-based procedures, supported by favorable reimbursement policies in many regions, is accelerating the adoption of these devices.

Furthermore, increasing awareness of early diagnosis and treatment, improvements in healthcare infrastructure in developing countries, and ongoing investments by major manufacturers in innovation and clinical research are all contributing to market growth.

“The old/normal balloons segment is expected to grow at the highest CAGR in the angioplasty balloons market during the forecast period.”

The angioplasty balloons market is experiencing increased demand for plain (standard) balloons due to their cost-effectiveness, availability of clinical expertise, and versatility across peripheral and coronary interventions. These balloons remain popular for lesion preparation, as well as for pre- and post-dilatation procedures, particularly when drug-coated options are either unnecessary or not covered by insurance. Despite the emergence of advanced balloon technologies, standard balloons continue to see strong sales in less demanding, high-volume markets, especially in developing countries, due to their ease of use, reliability, and compatibility with different stent systems.

“The embolic protection devices segment is expected to grow at the highest CAGR in the hemodynamic flow alteration devices market during the forecast period.”

Embolic protection devices are expected to see increased demand in the hemodynamic flow alteration devices market. This is due to their growing use in complex endovascular and structural heart procedures, where the risk of distal embolization is notably high. The rising awareness of procedure-related complications, such as stroke and organ ischemia—especially during carotid, peripheral, and transcatheter interventions—has accelerated their clinical adoption. Additionally, improvements in device design, which enhance capture efficiency, deliverability, and vessel compatibility, have significantly supported market growth. This trend is further bolstered by the introduction of established guidelines and the expansion of minimally invasive vascular procedures.

“Based on end users, the ambulatory surgical centers segment is expected to grow at the highest CAGR in the peripheral vascular devices market during the forecast period.”

The peripheral vascular devices market is experiencing significant growth, largely driven by the positive impact of ambulatory surgery centers (ASCs). These centers facilitate the shift toward minimally invasive procedures that prioritize the comfort and safety of outpatient care. ASCs offer numerous benefits, including lower procedural costs, faster patient turnover, shorter hospital stays, and improved operational efficiency, making them appealing to payers, providers, and patients alike. Innovations in peripheral vascular devices, such as miniaturized imaging systems, low-profile catheters, balloons, and atherectomy devices, have enabled even the most complex procedures to be performed in ASC settings. Additionally, favorable reimbursement policies, physician ownership models, increasing patient preference for same-day discharge, and the rising incidence of peripheral artery disease (PAD) are all contributing to the accelerated adoption of ASCs in this market.

“The Asia Pacific is estimated to register the highest CAGR during the forecast period.”

The primary driver of the peripheral vascular devices market in the APAC region is the rapidly increasing incidence of peripheral artery disease (PAD) and diabetes. This trend is supported by a large aging population and a global shift towards healthier lifestyles. Countries like China, India, and Japan are leading the way in adopting these devices, driven by developing healthcare infrastructure, rising healthcare expenditures, and improved access to advanced endovascular procedures. Additionally, growing awareness of the benefits of minimally invasive interventions, an increasing number of skilled interventional specialists, and a gradual but steady expansion of reimbursement coverage in key markets are also contributing to market growth. Furthermore, low-cost manufacturing, the presence of local companies, and the strategic expansion of global medical device firms are significant drivers of this market's growth in the APAC region.

Key Players

Some of the major players in this market are Boston Scientific (US), Medtronic Plc (US), Abbott (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), B. Braun Melsungen AG (Germany), Merit Medical Systems (US), Penumbra, Inc. (US), Koninklijke Philips (Netherlands), Stryker (US), Cordis (US), W.L. Gore & Associates (US), Biotronik Stryker (US), Endologix LLC (US), and Cook Medical (US), among others.

Research Coverage

The report analyzes the peripheral vascular devices market, estimating market size and future growth potential across various segments. These segments include angioplasty stents, endovascular aneurysm repair stent grafts, inferior vena cava filters, catheters, angioplasty balloons, plaque modification devices, hemodynamic flow alteration devices, other devices, and end users. Additionally, the report includes a product portfolio matrix of various peripheral vascular devices available in the market. It also provides a competitive analysis of the key players in this market, detailing their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report

This report will provide market leaders and new entrants with valuable revenue estimates for the overall peripheral vascular devices market and its subsegments. It will help stakeholders understand the competitive landscape, enabling them to better position their businesses and develop effective go-to-market strategies. Additionally, the report will offer insights into the current market dynamics, highlighting key drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (rapid growth in geriatric population and resulting increase in disease prevalence and favorable reimbursement scenario for peripheral vascular procedures), restraints (availability of alternative treatment options and shortage of skilled professionals with expertise in peripheral vascular devices), opportunities (high growth potential in emerging markets and growing incidence of obesity & diabetes), and challenges (product failures and device recalls).
• Product Developments/Enhancements: Comprehensive details about new product launches and anticipated trends in the global peripheral vascular devices market.
• Product Innovation: Detailed insights on upcoming trends, research & development activities, and new product launches in the global peripheral vascular devices market.
• Market Development: Comprehensive information on the lucrative emerging markets by angioplasty stents, structural heart devices, catheters, angioplasty balloons, plaque modification devices, hemodynamic flow alteration devices, other devices, and end users.
• Market Diversification: Exhaustive information about new products and services or product and service enhancements, growing geographies, recent developments, and investments in the global peripheral vascular devices market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products and services, and capacities of the major competitors in the global peripheral vascular devices market.

Show more